So far, we do not have any published database regarding HCT patients during the present pandemic. We herein describe the first case of COVID-19 presenting in the early hematopoietic cell transplantation (HCT) setting.

Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting

Spadea, Manuela
First
;
Fagioli, Franca
2021-01-01

Abstract

So far, we do not have any published database regarding HCT patients during the present pandemic. We herein describe the first case of COVID-19 presenting in the early hematopoietic cell transplantation (HCT) setting.
2021
23
2
e13470
e13474
http://dx.doi.org/10.1111/tid.13470
COVID-19 management; hematopoietic cell transplantation; immune suppressed patients; invasive aspergillosis co-infection; ruxolitinib; severe COVID-19
Spadea, Manuela; Carraro, Francesca; Saglio, Francesco; Vassallo, Elena; Pessolano, Rosanna; Berger, Massimo; Scolfaro, Carlo; Grassitelli, Sergio; Fagioli, Franca
File in questo prodotto:
File Dimensione Formato  
2020 Successfully treated_Spadea.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 685.07 kB
Formato Adobe PDF
685.07 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1757307
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact